🇺🇸 FDA
Pipeline program

JEMPERLI 500 mg concentrate for solution for infusion

GEICO78-C (ATOMICC)

Phase 2 small_molecule active

Quick answer

JEMPERLI 500 mg concentrate for solution for infusion for Cervical cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cancer Prevention Pharma (Ireland) Limited
Indication
Cervical cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials